Australia Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Australia Gene Synthesis Research Use Market, worth USD 120 million, grows with investments in synthetic biology and gene editing technologies.

Region:Asia

Author(s):Geetanshi

Product Code:KRAA4152

Pages:80

Published On:January 2026

About the Report

Base Year 2024

Australia Gene Synthesis Research Use Market Overview

  • The Australia Gene Synthesis Research Use Market is valued at approximately USD 120 million, based on a five-year historical analysis of the broader Australia gene synthesis market and its research-focused demand profile. This growth is primarily driven by advancements in biotechnology, increasing research activities in genomics, and the rising demand for synthetic biology applications, in line with global gene synthesis trends. The market has seen a surge in investments from both public and private sectors in areas such as synthetic biology, regenerative medicine, and genomics infrastructure, enhancing the capabilities and accessibility of gene synthesis technologies in Australia.
  • Key players in this market are concentrated in major cities such as Sydney, Melbourne, and Brisbane. These cities dominate due to their robust research infrastructure, presence of leading academic institutions, and a thriving biotech industry, including hubs around the University of Sydney, UNSW Sydney, University of Melbourne, Monash University, and major medical research institutes. The collaboration between universities, Cooperative Research Centres, and biotech firms in these regions fosters innovation and accelerates the development and use of gene synthesis technologies in applications such as synthetic biology, therapeutics, and diagnostics.
  • In 2023, the Australian government implemented the National Biotechnology Strategy, which aims to support the growth of the biotechnology sector, including gene synthesis, with a focus on strengthening sovereign capability and industry–research translation. This strategy includes funding initiatives and regulatory and policy frameworks designed to enhance research capabilities and promote collaboration between industry and academia, ultimately driving advancements in gene synthesis technologies. In parallel, activities in gene synthesis and related DNA technologies are governed by instruments such as the Gene Technology Act 2000 administered by the Office of the Gene Technology Regulator, which establishes licensing, risk assessment, and containment requirements for dealings with genetically modified organisms relevant to synthetic and engineered genetic material used in research.
Australia Gene Synthesis Research Use Market Size

Australia Gene Synthesis Research Use Market Segmentation

By Product & Service:The product and service segmentation of the market includes various offerings that cater to the diverse needs of researchers and organizations involved in gene synthesis. The subsegments include gene synthesis services, gene synthesis kits & reagents, gene fragments & oligonucleotides for research, GMP-grade gene synthesis for clinical research use, and others. This structure aligns with typical global gene synthesis offerings, where custom gene synthesis services, oligonucleotide products, and associated reagents form the core of the commercial portfolio. Among these, gene synthesis services are the most dominant due to their tailored solutions, increasing complexity of synthetic constructs, and high demand from academic and commercial research entities seeking outsourced, high-accuracy synthesis and design support.

Australia Gene Synthesis Research Use Market segmentation by Product & Service.

By Application:The application segmentation encompasses various fields where gene synthesis is utilized, including basic genetic & molecular biology research, synthetic biology & genome engineering, cell & gene therapy research, vaccine, antibody & protein engineering research, agricultural & industrial biotechnology research, and others. These application clusters are consistent with how global markets characterize demand for gene synthesis across research and preclinical domains. The cell & gene therapy research segment is currently leading the market due to the increasing focus on personalized medicine, engineered cell therapies, and nucleic-acid-based therapeutics, which require complex custom gene constructs and vector designs.

Australia Gene Synthesis Research Use Market segmentation by Application.

Australia Gene Synthesis Research Use Market Competitive Landscape

The Australia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Integrated DNA Technologies (IDT), Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, Codex DNA / Telesis Bio, Bioneer Corporation, ATUM, GENEWIZ (Azenta Life Sciences), Bio Basic Inc., LGC Biosearch Technologies, Jena Bioscience GmbH, Genetic Signatures Ltd (Australia), Starpharma Holdings Limited (Australia), Agilent Technologies Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Integrated DNA Technologies (IDT)

1987

Coralville, Iowa, USA

Thermo Fisher Scientific Inc.

2006

Waltham, Massachusetts, USA

GenScript Biotech Corporation

2002

Nanjing, China

Eurofins Genomics

2000

Luxembourg City, Luxembourg

Twist Bioscience Corporation

2013

San Francisco, California, USA

Company

Establishment Year

Headquarters

Company type and size (global, regional; large, mid, small)

Australia gene synthesis research-use revenue (AUD, latest year)

3-year Australia revenue CAGR

Share of revenue from research-use gene synthesis (%)

Average selling price per base pair / per construct

Average turnaround time (business days) by construct length

Australia Gene Synthesis Research Use Market Industry Analysis

Growth Drivers

  • Increasing Demand for Synthetic Biology Applications:The Australian synthetic biology market is projected to reach AUD 1.5 billion in future, driven by the rising demand for innovative solutions in healthcare, agriculture, and environmental sustainability. The biotechnology sector's contribution to the Australian economy is expected to grow by 5% in future, reflecting a robust interest in synthetic biology applications. This growth is supported by government initiatives aimed at fostering research and development in synthetic biology, enhancing the overall market landscape.
  • Advancements in Gene Editing Technologies:The gene editing market in Australia is anticipated to expand significantly, with investments in CRISPR and other gene editing technologies projected to exceed AUD 300 million in future. These advancements are crucial for developing targeted therapies and improving crop resilience. The Australian government has allocated AUD 50 million to support research in gene editing, indicating a strong commitment to advancing these technologies and their applications in various sectors, including agriculture and medicine.
  • Rising Investment in Biotechnology Research:In future, Australia's biotechnology sector is expected to receive over AUD 1 billion in funding, reflecting a growing interest from both public and private sectors. This investment is crucial for driving innovation in gene synthesis and related technologies. The Australian government has introduced several funding programs, including the Biomedical Translation Fund, which aims to support the commercialization of biotechnology research, thereby enhancing the market's growth potential and fostering a vibrant research ecosystem.

Market Challenges

  • High Costs Associated with Gene Synthesis:The cost of gene synthesis in Australia can range from AUD 500 to AUD 10,000 per gene, depending on complexity and length. These high costs pose a significant barrier for many research institutions and startups, limiting their ability to access advanced gene synthesis technologies. As a result, the market may experience slower growth, particularly among smaller entities that lack the financial resources to invest in these essential technologies.
  • Regulatory Hurdles in Genetic Research:The regulatory landscape for genetic research in Australia is complex, with stringent guidelines governing gene editing and synthetic biology applications. Compliance with these regulations can lead to delays in research and development timelines, impacting the overall market growth. In future, it is estimated that compliance costs could account for up to 20% of total research budgets, creating additional challenges for researchers and companies operating in this space.

Australia Gene Synthesis Research Use Market Future Outlook

The future of the Australia gene synthesis research use market appears promising, driven by technological advancements and increasing applications across various sectors. The integration of artificial intelligence in gene synthesis processes is expected to enhance efficiency and accuracy, while the growing focus on personalized medicine will further stimulate demand. Additionally, collaborations between industry and academic institutions are likely to foster innovation, leading to new breakthroughs in gene synthesis technologies and applications, ultimately benefiting the healthcare and agricultural sectors.

Market Opportunities

  • Expansion of Personalized Medicine:The personalized medicine market in Australia is projected to reach AUD 2 billion in future, creating significant opportunities for gene synthesis applications. This growth is driven by advancements in genomics and the increasing demand for tailored therapies, which require precise gene synthesis technologies to develop effective treatments for individual patients.
  • Collaborations with Academic Institutions:Partnerships between biotechnology companies and academic institutions are expected to increase, with over AUD 150 million allocated for collaborative research projects in future. These collaborations can enhance innovation in gene synthesis technologies, leading to the development of novel applications and solutions that address pressing challenges in healthcare and agriculture.

Scope of the Report

SegmentSub-Segments
By Product & Service

Gene synthesis services

Gene synthesis kits & reagents

Gene fragments & oligonucleotides for research

GMP-grade gene synthesis for clinical research use

Others

By Application

Basic genetic & molecular biology research

Synthetic biology & genome engineering

Cell & gene therapy research

Vaccine, antibody & protein engineering research

Agricultural & industrial biotechnology research

Others

By Synthesis Method

Solid-phase synthesis

Chip-based DNA synthesis

PCR-based enzyme synthesis

Others

By End-User

Academic & research institutes

Biotech companies

Pharmaceutical & biopharmaceutical companies

CROs and CDMOs

Government & public research organizations

Others

By Region

New South Wales

Victoria

Queensland

Western Australia

South Australia

Rest of Australia

By Order Scale

Small-scale custom orders (<5 kb)

Medium-scale orders (5–50 kb)

Large-scale & high-throughput projects (>50 kb, libraries)

Others

By Funding Source

Competitive government grants

Institutional & university core funding

Venture capital & private equity

Corporate R&D budgets

Philanthropic & non-profit funding

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Australian Government Department of Health, Therapeutic Goods Administration)

Biotechnology Companies

Pharmaceutical Companies

Research Institutions and Laboratories

Biomanufacturing Firms

Healthcare Providers and Organizations

Non-Profit Organizations and Foundations

Players Mentioned in the Report:

Integrated DNA Technologies (IDT)

Thermo Fisher Scientific Inc.

GenScript Biotech Corporation

Eurofins Genomics

Twist Bioscience Corporation

Codex DNA / Telesis Bio

Bioneer Corporation

ATUM

GENEWIZ (Azenta Life Sciences)

Bio Basic Inc.

LGC Biosearch Technologies

Jena Bioscience GmbH

Genetic Signatures Ltd (Australia)

Starpharma Holdings Limited (Australia)

Agilent Technologies Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Australia Gene Synthesis Research Use Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Australia Gene Synthesis Research Use Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Australia Gene Synthesis Research Use Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for synthetic biology applications
3.1.2 Advancements in gene editing technologies
3.1.3 Rising investment in biotechnology research
3.1.4 Growing prevalence of genetic disorders

3.2 Market Challenges

3.2.1 High costs associated with gene synthesis
3.2.2 Regulatory hurdles in genetic research
3.2.3 Limited awareness among end-users
3.2.4 Competition from alternative technologies

3.3 Market Opportunities

3.3.1 Expansion of personalized medicine
3.3.2 Collaborations with academic institutions
3.3.3 Development of cost-effective synthesis methods
3.3.4 Increasing applications in agriculture

3.4 Market Trends

3.4.1 Shift towards automation in gene synthesis
3.4.2 Growth of CRISPR technology adoption
3.4.3 Rising focus on ethical considerations in genetic research
3.4.4 Integration of AI in gene synthesis processes

3.5 Government Regulation

3.5.1 Guidelines for genetic research and applications
3.5.2 Compliance requirements for synthetic biology
3.5.3 Funding programs for biotechnology research
3.5.4 Intellectual property regulations in gene synthesis

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Australia Gene Synthesis Research Use Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Australia Gene Synthesis Research Use Market Segmentation

8.1 By Product & Service

8.1.1 Gene synthesis services
8.1.2 Gene synthesis kits & reagents
8.1.3 Gene fragments & oligonucleotides for research
8.1.4 GMP-grade gene synthesis for clinical research use
8.1.5 Others

8.2 By Application

8.2.1 Basic genetic & molecular biology research
8.2.2 Synthetic biology & genome engineering
8.2.3 Cell & gene therapy research
8.2.4 Vaccine, antibody & protein engineering research
8.2.5 Agricultural & industrial biotechnology research
8.2.6 Others

8.3 By Synthesis Method

8.3.1 Solid-phase synthesis
8.3.2 Chip-based DNA synthesis
8.3.3 PCR-based enzyme synthesis
8.3.4 Others

8.4 By End-User

8.4.1 Academic & research institutes
8.4.2 Biotech companies
8.4.3 Pharmaceutical & biopharmaceutical companies
8.4.4 CROs and CDMOs
8.4.5 Government & public research organizations
8.4.6 Others

8.5 By Region

8.5.1 New South Wales
8.5.2 Victoria
8.5.3 Queensland
8.5.4 Western Australia
8.5.5 South Australia
8.5.6 Rest of Australia

8.6 By Order Scale

8.6.1 Small-scale custom orders (<5 kb)
8.6.2 Medium-scale orders (5–50 kb)
8.6.3 Large-scale & high-throughput projects (>50 kb, libraries)
8.6.4 Others

8.7 By Funding Source

8.7.1 Competitive government grants
8.7.2 Institutional & university core funding
8.7.3 Venture capital & private equity
8.7.4 Corporate R&D budgets
8.7.5 Philanthropic & non-profit funding
8.7.6 Others

9. Australia Gene Synthesis Research Use Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company name
9.2.2 Company type and size (global, regional; large, mid, small)
9.2.3 Australia gene synthesis research-use revenue (AUD, latest year)
9.2.4 3-year Australia revenue CAGR
9.2.5 Share of revenue from research-use gene synthesis (%)
9.2.6 Average selling price per base pair / per construct
9.2.7 Average turnaround time (business days) by construct length
9.2.8 Capacity utilization rate of synthesis facilities (%)
9.2.9 Number of active Australia research customers
9.2.10 Customer concentration (top 10 customers’ revenue share %)
9.2.11 Customer retention rate (%) – research accounts
9.2.12 New customer additions per year (number and % growth)
9.2.13 R&D intensity (% of revenue invested in R&D)
9.2.14 Gross margin and EBITDA margin (%) – Australia operations
9.2.15 Order mix by length/complexity (short genes, long genes, libraries)
9.2.16 On-time delivery rate (%)
9.2.17 IP portfolio indicators (patents, proprietary platforms)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Integrated DNA Technologies (IDT)
9.5.2 Thermo Fisher Scientific Inc.
9.5.3 GenScript Biotech Corporation
9.5.4 Eurofins Genomics
9.5.5 Twist Bioscience Corporation
9.5.6 Codex DNA / Telesis Bio
9.5.7 Bioneer Corporation
9.5.8 ATUM
9.5.9 GENEWIZ (Azenta Life Sciences)
9.5.10 Bio Basic Inc.
9.5.11 LGC Biosearch Technologies
9.5.12 Jena Bioscience GmbH
9.5.13 Genetic Signatures Ltd (Australia)
9.5.14 Starpharma Holdings Limited (Australia)
9.5.15 Agilent Technologies Inc.

10. Australia Gene Synthesis Research Use Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers
10.1.4 Compliance Requirements

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends
10.2.2 Budget Prioritization
10.2.3 Long-term Contracts
10.2.4 Cost Management Strategies

10.3 Pain Point Analysis by End-User Category

10.3.1 Research Limitations
10.3.2 Budget Constraints
10.3.3 Technology Gaps
10.3.4 Regulatory Compliance Issues

10.4 User Readiness for Adoption

10.4.1 Training Needs
10.4.2 Infrastructure Readiness
10.4.3 Technology Acceptance
10.4.4 Support Requirements

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 User Feedback
10.5.3 Scalability Potential
10.5.4 Future Investment Plans

11. Australia Gene Synthesis Research Use Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Streams Analysis

1.4 Cost Structure Evaluation

1.5 Key Partnerships Exploration

1.6 Customer Segmentation

1.7 Competitive Advantage Assessment


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs

2.3 Target Audience Identification

2.4 Communication Channels

2.5 Marketing Budget Allocation

2.6 Performance Metrics

2.7 Feedback Mechanisms


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups

3.3 Online Distribution Channels

3.4 Direct Sales Approaches

3.5 Logistics and Supply Chain Management

3.6 Partnership Opportunities

3.7 Distribution Cost Analysis


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis

4.3 Competitor Pricing Strategies

4.4 Customer Willingness to Pay

4.5 Price Sensitivity Assessment

4.6 Discounting Strategies

4.7 Pricing Model Innovation


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments

5.3 Emerging Trends

5.4 Customer Pain Points

5.5 Market Research Insights

5.6 Future Demand Projections

5.7 Product Development Opportunities


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service

6.3 Customer Engagement Strategies

6.4 Feedback and Improvement Processes

6.5 Relationship Management Tools

6.6 Customer Retention Strategies

6.7 Community Building Initiatives


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains

7.3 Unique Selling Points

7.4 Customer-Centric Innovations

7.5 Competitive Differentiation

7.6 Value Delivery Mechanisms

7.7 Market Positioning Strategies


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Initiatives

8.3 Distribution Setup

8.4 Marketing Campaigns

8.5 Training and Development

8.6 Performance Monitoring

8.7 Stakeholder Engagement


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging Considerations

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model

10.5 Risk Assessment

10.6 Strategic Partnerships

10.7 Market Adaptation Strategies


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation

11.3 Financial Projections

11.4 Funding Sources

11.5 Budget Allocation

11.6 Risk Management Plans

11.7 Milestone Tracking


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships

12.2 Risk Mitigation Strategies

12.3 Control Mechanisms

12.4 Partnership Evaluation Criteria

12.5 Long-term Strategic Goals

12.6 Flexibility in Operations

12.7 Exit Strategies


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability

13.3 Profit Margin Projections

13.4 Cost Management Strategies

13.5 Revenue Growth Strategies

13.6 Financial Health Indicators

13.7 Investment Returns


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets

14.4 Strategic Alliances

14.5 Research Collaborations

14.6 Technology Partners

14.7 Funding Partners


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking
15.2.3 Performance Evaluation
15.2.4 Adjustments and Iterations

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from Australian biotechnology associations and research institutions
  • Review of academic publications and journals focusing on gene synthesis technologies
  • Examination of government publications and funding initiatives related to genetic research

Primary Research

  • Interviews with key opinion leaders in the gene synthesis field, including researchers and industry experts
  • Surveys targeting biotechnology firms and academic institutions engaged in gene synthesis
  • Field interviews with laboratory managers and R&D directors to gather insights on operational needs

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including market reports and expert interviews
  • Triangulation of quantitative data with qualitative insights from industry stakeholders
  • Sanity checks conducted through expert panel reviews to ensure data reliability

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the gene synthesis market size based on national biotechnology spending trends
  • Segmentation of the market by application areas such as pharmaceuticals, agriculture, and research
  • Incorporation of government and private sector investments in genetic research initiatives

Bottom-up Modeling

  • Collection of data on gene synthesis service pricing from leading providers in Australia
  • Estimation of market volume based on the number of projects and average project size
  • Analysis of customer segments and their respective demand for gene synthesis services

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating trends in biotechnology advancements and funding
  • Scenario modeling based on potential regulatory changes and market entry of new technologies
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Gene Synthesis120Research Scientists, Product Development Managers
Agricultural Biotechnology Applications90Biotech Researchers, Agronomists
Academic Research Institutions80University Professors, Lab Directors
Clinical Research Organizations70Clinical Project Managers, Regulatory Affairs Specialists
Startups in Gene Editing Technologies60Founders, CTOs, and Innovation Managers

Frequently Asked Questions

What is the current value of the Australia Gene Synthesis Research Use Market?

The Australia Gene Synthesis Research Use Market is valued at approximately USD 120 million, reflecting a robust demand profile driven by advancements in biotechnology and increasing research activities in genomics and synthetic biology applications.

What factors are driving growth in the Australia Gene Synthesis Research Use Market?

Which cities in Australia are leading in gene synthesis research?

What is the National Biotechnology Strategy in Australia?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022